Peptidase inhibitor (PI16) impairs bladder cancer metastasis by inhibiting NF-κB activation via disrupting multiple-site ubiquitination of NEMO

BACKGROUND: Bladder cancer (BLCA) is a malignancy that frequently metastasizes and leads to poor patient prognosis. It is essential to understand the molecular mechanisms underlying the progression and metastasis of BLCA and identify potential biomarkers. METHODS: The expression of peptidase inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuang, Xiangqin, Zhang, Zhuojun, Li, Difeng, Bao, Wenhao, Pan, Jinyuan, Zhou, Ping, Chen, Han, Gao, Zhiqing, Xie, Xiaoyi, Yang, Chunxiao, Zhu, Ge, Zhou, Zhongqiu, Tang, Ruiming, Feng, Zhengfu, Zhou, Lihuan, Feng, Xiaoli, Wang, Lan, Yang, Jianan, Jiang, Lili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388466/
https://www.ncbi.nlm.nih.gov/pubmed/37525118
http://dx.doi.org/10.1186/s11658-023-00465-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388466/
https://www.ncbi.nlm.nih.gov/pubmed/37525118
http://dx.doi.org/10.1186/s11658-023-00465-6

Ejemplares similares